| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Chief Scientific Officer
1 company
Lyssikatos Joseph P is a Chief Scientific Officer at Enliven Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $33.4M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 6, 2026 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,000 | $29.04 | $145,219.00 | -0.7% | +36.9% | - | |
| Jan 9, 2026 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 132,500 | $26.23 | $3,476,013.95 | -3.8% | +75.3% | - | |
| Dec 19, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 5,000 | $16.84 | $84,206.00 | -0.6% | +78.1% | - | |
| Nov 19, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 12,500 | $22.33 | $279,154.78 | -0.7% | +18.2% | - | |
| Oct 20, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 12,500 | $22.08 | $276,025.00 | -1.3% | +22.3% | - | |
| Sep 26, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 4,000 | $20.25 | $81,005.20 | -0.4% | -18.5% | - | |
| Sep 23, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 1,500 | $20.03 | $30,045.00 | -0.2% | -6.6% | - | |
| Sep 19, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 7,000 | $19.39 | $135,697.35 | -0.4% | -12.0% | - | |
| Aug 21, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 12,500 | $19.86 | $248,216.50 | -0.7% | +11.4% | - | |
| Jul 21, 2025 | ELVN Enliven Therapeutics, Inc. | Chief Scientific Officer | Sell | 12,500 | $22.29 | $278,645.80 | -0.7% | +1.1% | - |